Synergy Innovation Co. Ltd (048870) - Net Assets
Based on the latest financial reports, Synergy Innovation Co. Ltd (048870) has net assets worth ₩282.74 Billion KRW (≈ $191.61 Million USD) as of June 2026. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (₩345.29 Billion ≈ $234.00 Million USD) and total liabilities (₩62.55 Billion ≈ $42.39 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check 048870 strategic asset allocation to assess the company's strategic physical and investment asset allocation.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | ₩282.74 Billion |
| % of Total Assets | 81.88% |
| Annual Growth Rate | 4.81% |
| 5-Year Change | 139.07% |
| 10-Year Change | 1922.62% |
| Growth Volatility | 61.02 |
Synergy Innovation Co. Ltd - Net Assets Trend (2006–2025)
This chart illustrates how Synergy Innovation Co. Ltd's net assets have evolved over time, based on quarterly financial data. For live market cap and overall valuation, see Synergy Innovation Co. Ltd market cap and net worth.
Annual Net Assets for Synergy Innovation Co. Ltd (2006–2025)
The table below shows the annual net assets of Synergy Innovation Co. Ltd from 2006 to 2025. Also explore net asset growth rate of Synergy Innovation Co. Ltd to track the company's year-over-year net asset growth rate.
| Year | Net Assets | Change |
|---|---|---|
| 2025-12-31 | ₩272.39 Billion ≈ $184.60 Million |
+49.06% |
| 2024-12-31 | ₩182.74 Billion ≈ $123.84 Million |
-17.90% |
| 2023-12-31 | ₩222.59 Billion ≈ $150.84 Million |
+59.09% |
| 2022-12-31 | ₩139.91 Billion ≈ $94.82 Million |
+22.80% |
| 2021-12-31 | ₩113.94 Billion ≈ $77.21 Million |
+43.85% |
| 2020-12-31 | ₩79.21 Billion ≈ $53.68 Million |
+5.53% |
| 2019-12-31 | ₩75.05 Billion ≈ $50.86 Million |
+39.52% |
| 2018-12-31 | ₩53.79 Billion ≈ $36.45 Million |
+74.02% |
| 2017-12-31 | ₩30.91 Billion ≈ $20.95 Million |
+129.54% |
| 2016-12-31 | ₩13.47 Billion ≈ $9.13 Million |
+168.84% |
| 2015-12-31 | ₩-19.56 Billion ≈ $-13.26 Million |
-165.01% |
| 2014-12-31 | ₩30.09 Billion ≈ $20.39 Million |
-28.78% |
| 2013-12-31 | ₩42.26 Billion ≈ $28.64 Million |
-44.08% |
| 2012-12-31 | ₩75.56 Billion ≈ $51.21 Million |
+6.30% |
| 2011-12-31 | ₩71.09 Billion ≈ $48.17 Million |
-30.49% |
| 2009-12-31 | ₩102.27 Billion ≈ $69.31 Million |
-23.95% |
| 2008-12-31 | ₩134.48 Billion ≈ $91.13 Million |
+0.67% |
| 2007-12-31 | ₩133.58 Billion ≈ $90.53 Million |
+19.81% |
| 2006-12-31 | ₩111.49 Billion ≈ $75.56 Million |
-- |
Equity Component Analysis
This analysis shows how different components contribute to Synergy Innovation Co. Ltd's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 6900565897000.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2025)
| Component | Amount | Percentage |
|---|---|---|
| Other Components | ₩280.52 Billion | 132.62% |
| Total Equity | ₩211.51 Billion | 100.00% |
Synergy Innovation Co. Ltd Competitors by Market Cap
The table below lists competitors of Synergy Innovation Co. Ltd ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Maywufa Co Ltd
TW:1731
|
$87.73 Million |
|
Perintis Triniti Properti PT
JK:TRIN
|
$87.73 Million |
|
Kumho Electric
KO:001210
|
$87.74 Million |
|
South Basic Chemicals JSC
VN:CSV
|
$87.74 Million |
|
MLG OZ Ltd
AU:MLG
|
$87.70 Million |
|
Kyongbo Pharmaceutical Co Ltd
KO:214390
|
$87.65 Million |
|
IFB Agro Industries Limited
NSE:IFBAGRO
|
$87.64 Million |
|
Taeyang Metal Industrial Co Ltd
KO:004105
|
$87.63 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Synergy Innovation Co. Ltd's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 182,735,808,750 to 211,513,428,260, a change of 28,777,619,510 (15.7%).
- Net income of 3,011,341,240 contributed positively to equity growth.
- Dividend payments of 1,546,567,800 reduced retained earnings.
- Other factors increased equity by 27,312,846,070.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | ₩3.01 Billion | +1.42% |
| Dividends Paid | ₩1.55 Billion | -0.73% |
| Other Changes | ₩27.31 Billion | +12.91% |
| Total Change | ₩- | 15.75% |
Book Value vs Market Value Analysis
This analysis compares Synergy Innovation Co. Ltd's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 0.61x
- The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
- The price-to-book ratio has decreased from 4.84x to 0.61x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2016-12-31 | ₩303.42 | ₩1469.00 | x |
| 2017-12-31 | ₩559.53 | ₩1469.00 | x |
| 2018-12-31 | ₩936.73 | ₩1469.00 | x |
| 2019-12-31 | ₩1152.75 | ₩1469.00 | x |
| 2020-12-31 | ₩1080.44 | ₩1469.00 | x |
| 2021-12-31 | ₩1432.55 | ₩1469.00 | x |
| 2022-12-31 | ₩1691.63 | ₩1469.00 | x |
| 2023-12-31 | ₩2152.74 | ₩1469.00 | x |
| 2024-12-31 | ₩2209.40 | ₩1469.00 | x |
| 2025-12-31 | ₩2400.64 | ₩1469.00 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Synergy Innovation Co. Ltd utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 1.42%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 2.66%
- • Asset Turnover: 0.34x
- • Equity Multiplier: 1.59x
- Recent ROE (1.42%) is below the historical average (3.86%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2006 | 23.56% | 13.74% | 1.39x | 1.23x | ₩15.04 Billion |
| 2007 | 1.47% | 1.58% | 0.80x | 1.17x | ₩-11.39 Billion |
| 2008 | 2.10% | 2.99% | 0.53x | 1.33x | ₩-10.62 Billion |
| 2014 | -40.59% | -39.02% | 0.38x | 2.73x | ₩-15.21 Billion |
| 2015 | 0.00% | -345.14% | 0.92x | 0.00x | ₩-49.37 Billion |
| 2016 | 101.51% | 87.53% | 0.26x | 4.43x | ₩12.32 Billion |
| 2017 | -30.03% | -27.14% | 0.32x | 3.43x | ₩-12.37 Billion |
| 2018 | -2.52% | -3.22% | 0.34x | 2.27x | ₩-6.73 Billion |
| 2019 | 4.46% | 6.13% | 0.37x | 1.96x | ₩-4.16 Billion |
| 2020 | -27.03% | -31.06% | 0.44x | 2.00x | ₩-29.33 Billion |
| 2021 | 5.02% | 18.63% | 0.15x | 1.78x | ₩-5.67 Billion |
| 2022 | 11.53% | 18.64% | 0.38x | 1.63x | ₩2.14 Billion |
| 2023 | 1.29% | 2.77% | 0.29x | 1.61x | ₩-15.50 Billion |
| 2024 | 5.68% | 11.45% | 0.29x | 1.72x | ₩-7.90 Billion |
| 2025 | 1.42% | 2.66% | 0.34x | 1.59x | ₩-18.14 Billion |
Industry Comparison
This section compares Synergy Innovation Co. Ltd's net assets metrics with peer companies in the Biotechnology industry.
Industry Context
- Industry: Biotechnology
- Average net assets among peers: $374,207,764,170
- Average return on equity (ROE) among peers: -9.63%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Synergy Innovation Co. Ltd (048870) | ₩282.74 Billion | 23.56% | 0.22x | $87.71 Million |
| ORIENTBIO Inc. (002630) | $51.96 Billion | -20.94% | 0.39x | $73.37 Million |
| Green Cross (005250) | $1.88 Trillion | -2.88% | 0.99x | $295.07 Million |
| Green Cross Holdings Preference Shares (005257) | $1.44 Trillion | 3.01% | 0.78x | $2.94 Million |
| Pharmicell (005690) | $82.82 Billion | -21.94% | 0.22x | $470.89 Million |
| GeneOne Life Science Inc (011000) | $98.51 Billion | -18.93% | 0.39x | $32.81 Million |
| HLB Co. Ltd (028300) | $23.02 Billion | -12.73% | 1.36x | $2.88 Billion |
| Mgenplus Co. Ltd. (032790) | $17.38 Billion | 0.00% | 1.46x | $22.01 Million |
| Daesung Microbiological Labs. Co. Ltd (036480) | $37.00 Billion | 2.34% | 0.69x | $15.81 Million |
| Seoulin Bioscience Co.Ltd (038070) | $48.60 Billion | 8.38% | 0.37x | $24.32 Million |
| Hyundai Bioscience Co. Ltd (048410) | $61.57 Billion | -32.57% | 0.31x | $435.56 Million |
About Synergy Innovation Co. Ltd
Synergy Innovation Co., Ltd. engages in the research and development, and investment of generic and new drugs, medical devices, and health functional foods in South Korea. It produces and sells various culture media for hospitals, pharmaceuticals, and food/cosmetics; manufactures synergy innovation " universal transport solutions (SI-UTS); and invests and develops in various fields comprising mic… Read more